Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. - Wikidata - wikimedia - TriplyDB

Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.

Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.

http://www.wikidata.org/entity/Q35022718

about

Development of polymeric micelles for targeting intractable cancers Hybrid nanoparticles for detection and treatment of cancer Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics Echographic imaging of tumoral cells through novel nanosystems for image diagnosis.Polymeric nanoparticles for targeted treatment in oncology: current insights Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles.Multifunctional polymeric micelles for delivery of drugs and siRNA.Gold nanoparticles: From nanomedicine to nanosensing.Polymeric micelles in anticancer therapy: targeting, imaging and triggered release.Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI.Zinc Oxide Nanocrystals for Non-resonant Nonlinear Optical Microscopy in Biology and Medicine Cooperative nanomaterial system to sensitize, target, and treat tumors.Design, synthesis, characterization and in-vivo activity of a novel salmon calcitonin conjugate containing a novel PEG-lipid moiety.Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity.Rational design of "heat seeking" drug loaded polypeptide nanoparticles that thermally target solid tumors.In vivo toxicologic study of larger silica nanoparticles in mice.Quantum dot loaded immunomicelles for tumor imaging.The benefits and challenges associated with the use of drug delivery systems in cancer therapy Strategy for increasing drug solubility and efficacy through covalent attachment to polyvalent DNA-nanoparticle conjugates.Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells.Enhanced tumor treatment using biofunctional indocyanine green-containing nanostructure by intratumoral or intravenous injection Doxorubicin-conjugated chimeric polypeptide nanoparticles that respond to mild hyperthermia.Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications Thermodynamic stability and relaxation studies of small, triaza-macrocyclic Mn(II) chelates.Laminin receptor-targeted etoposide loaded polymeric micelles: a novel approach for the effective treatment of tumor metastasis.Paclitaxel-loaded PEG-PE-based micellar nanopreparations targeted with tumor-specific landscape phage fusion protein enhance apoptosis and efficiently reduce tumors Rapid detection and destruction of squamous cell carcinoma of the head and neck by nano-quadrapeutics.De novo design of bioactive protein-resembling nanospheres via dendrimer-templated peptide amphiphile assembly.Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models.Impact of nanotechnology in cancer: emphasis on nanochemoprevention Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells Bioconjugated pluronic triblock-copolymer micelle-encapsulated quantum dots for targeted imaging of cancer: in vitro and in vivo studies.Development and qualification of an LC-MS/MS method for investigating the biological implications of micelle entrapped paclitaxel in cell culture and rats.Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines.Cancer cell spheroids as a model to evaluate chemotherapy protocols.Polymeric micelles for drug delivery.Targeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes

P2860

Q26749611-B7B6A338-AB58-419E-B6C9-9D7528B4AA99 Q26849404-AC97DFE1-8984-4446-8A5E-46CB7B267833 Q26860760-3B680FF1-1B84-434D-B6C8-9819DF95E03F Q27012856-73D3C33A-2A1E-4AF4-B03E-1CBBFF439C5D Q28087243-49EF684E-92D7-4C7A-804E-2A0BEE5D985B Q28282826-1704BAA8-6A35-4CD4-A227-DC281A4589BD Q28391849-79830550-3375-4D86-975B-700CB57DBDA2 Q30366990-4991F42D-ADC8-487E-9A60-C14C4A0E3534 Q30407976-612885F2-170F-4641-91CB-64566816FDF7 Q30438973-5A99FDE7-8A87-4D84-9AEE-602F87702C61 Q30447539-6BD0A9EA-DBDF-4CB8-9D45-4ECDFFDAF017 Q30478123-12184012-486D-46FA-8315-260A45822B56 Q33268808-EAE7DC67-682E-434F-8538-BA02137DE128 Q33487139-D5471434-384A-4F68-8B5A-E3005F615861 Q33524689-6B670A91-5BC4-46FA-898A-34C9F7DD1046 Q33582600-56298B57-7087-49D8-9EDD-AD1BFB35E645 Q33592506-377BFB3C-33BA-4E77-B07E-AB1EC96F66BA Q33629980-E547AFF7-B753-44C2-A1F1-6765F138A2CF Q33638113-234763BF-767D-4D7D-B962-2A8FCF7CF945 Q33721349-2AA9C6E4-BF64-4266-BCAC-73CE1E6C47AA Q33965271-2A704291-5001-4636-AAA2-649AACF2C5DA Q33980411-56D5F20A-282E-432A-A01B-CB6A9E30BDF5 Q34047136-234B7739-E965-4218-8D4B-E94DC8313657 Q34158431-84B9CFCC-0BE6-46EA-9AE6-D671000EFF2C Q34197322-22E7633B-FD15-4D71-9C4E-F45D281D80B9 Q34259986-E5890613-C1E8-491E-BE8D-72B668E00D50 Q34561711-5A1038E1-2E2C-4D8C-8170-3D12DAA00F08 Q34632779-70FFB559-3B18-41E0-A822-C379052ADEA9 Q34647228-0FB199E5-D5D8-4E07-92C2-2465ABE45627 Q35560212-0234D302-8AF9-4B22-95D9-35DAF9B3ABB4 Q35570289-7C00F525-DDDD-442D-9309-ECCEFEFB26D8 Q35674222-6D3BE381-DD11-4DA8-BAF3-C42E579B8C1A Q35750624-EE800FF9-B090-4023-BB56-AFF4EA576EB9 Q36119847-F4E184F4-4B64-43DA-B2E0-0F5EC0AF0C30 Q36163781-D0998690-CB56-48D6-83E1-AACEEA79E11B Q36282159-CB385D73-1042-4C43-BD31-59A926F2BE15 Q36294611-3545E409-24BE-41EC-9030-4D3608811121 Q36312156-CA1FC8B9-35BF-4C26-A1C5-322AE530D77C Q36349714-6BE9649A-5B22-446E-A1D9-5EF6EF6AD237 Q36381471-9D93D9D3-F189-415A-BF49-96C35291628C

P2860

Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.

http://www.wikidata.org/entity/Q35022718

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.

@ast

Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.

@en

type

label

Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.

@ast

Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.

@en

prefLabel

Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.

@ast

Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.

@en

P1433

Q35022718-3AE7FCE2-1E1F-4D34-BEAA-EE25099E758D

P1476

Q35022718-65C92D33-D2E7-42CF-BE50-29600B603B7E

P2093

Q35022718-3821B1E4-17A0-44BF-9333-63FDE3076E7A

Q35022718-82B70FBF-8A7A-49AF-9EFF-CAD6BC24C971

Q35022718-BF746E28-4684-466C-B451-3DDEC84D18CA

Q35022718-C8315127-9882-4E00-AB15-FA861CB2468D

P2860

Q35022718-125BE2A7-ABCD-484B-BA17-4C459B4DEB91

Q35022718-1AB5409F-02E8-49A1-B297-154D2AED31A2

Q35022718-2A6A59C3-4850-419B-A93B-A08AFFCC7FF3

Q35022718-2E7F4FD7-4EB6-4D1C-95D0-66982CA20CBF

Q35022718-498EF645-92F3-4023-AE84-E4B2CBFAC16B

Q35022718-560F7151-3ED3-49DF-97FF-1216281A3A67

Q35022718-657E9A9E-F539-48BC-BD2E-A261475E3CED

Q35022718-68D3D441-8D0C-4DFF-8ED8-90A7D77A506E

Q35022718-691895FA-D00D-4A9D-B6FD-8D184D5D7B6F

Q35022718-7B2D6EF1-1E72-4E1C-AEDC-2DB384499088

P304

Q35022718-C20173FA-157D-4319-A13C-7A076A8062EF

P31

Q35022718-4A6B234A-6C58-4986-AA0F-273BBC1D7EF2

P356

Q35022718-B1E38E2F-E3E6-4932-BCBB-16FFF61A7AED

P407

Q35022718-EFAA3294-3856-457C-B507-27402A53F6B4

P433

Q35022718-7F5A6D26-6C10-4C42-A967-2FD26B5FEB8C

P478

Q35022718-FDFD1255-C410-4410-B268-C45AB8576C86

P577

Q35022718-510FED3C-6EDF-492A-9770-BFCD05C3D5A7

P5875

Q35022718-2A3BC072-1F22-4C43-9EDD-D97A757FDD53

P698

Q35022718-AD92ABCD-A6D4-4DA9-9343-BC25D6EBCCF2

P932

Q35022718-1D692CBD-FE4D-48B8-BEB2-77749F72FCB9

P356

PNAS.0931428100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.

@en

P2093

Anatoly N Lukyanov

http://www.w3.org/2001/XMLSchema#string

Brigitte Papahadjopoulos-Sternberg

http://www.w3.org/2001/XMLSchema#string

Vladimir P Torchilin

http://www.w3.org/2001/XMLSchema#string

Zhonggao Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Tumor targeting using anti-her2 immunoliposomes.

A liposomal MRI contrast agent: phosphatidylethanolamine-DTPA.

Polymeric micelles - a new generation of colloidal drug carriers.

Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.

The mechanism of liposome accumulation in infarction.

Structure and design of polymeric surfactant-based drug delivery systems.

Monoclonal antibodies in the treatment of malignancy: basic concepts and recent developments.

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.

TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors.

P304

6039-6044

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0931428100

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7402467

http://www.w3.org/2001/XMLSchema#string

P698

12716967

http://www.w3.org/2001/XMLSchema#string

P932

156322

http://www.w3.org/2001/XMLSchema#string